Ocugen Initiates Phase 3 Clinical Trial of OCU310 for Dry Eye Disease

Monday, October 1, 2018 1 min read

Key Takeaway: Ocugen Initiates Phase 3 Clinical Trial of OCU310 for Dry Eye Disease